Japan's Ono Pharma inks exclusive license agreement with Biohaven to develop and commercialise IgG degraders in Japan, South ...

In addition to the NMPA's approval of CAMCEVI ® 42 mg for advanced prostate cancer described above, GenSci submitted a ...

Philanthropy Asia Alliance backs the NUS Medicine-based Southeast Asia Heat Health Hub, supporting heat-health action in ...

Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for core ...

S$25 million Healthy Longevity Institute and global brain health collaboration to advance healthy ageing in Singapore ...

Marengo Asia Hospitals and BAPIO Training Academy, in association with the Ministry of Ayush, Government of India, have ...

NEXT&BIO established an academic joint research laboratory with CSI Singapore at NUS in August 2025, followed by the ...

NUS launches S$50M National Centre for Engineering Biology to accelerate AI-guided sustainable biomanufacturing ...

US-based Danaher Corporation has announced plans to launch its first AI-powered autonomous lab, designed to help researchers ...

Since acquiring the global rights to edaravone, a treatment for amyotrophic lateral sclerosis (ALS), known as RADICAVA ® in ...

Germfree has launched a configurable Grade A aseptic biopharmaceutical isolator designed to support contamination control and ...

Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, US. Building ...